Association of serum homocysteine with major depressive disorder: results from a large population-based study.


Autoria(s): Nabi H.; Bochud M.; Glaus J.; Lasserre A.M.; Waeber G.; Vollenweider P.; Preisig M.
Data(s)

2013

Resumo

BACKGROUND: Studies on the association between homocysteine levels and depression have shown conflicting results. To examine the association between serum total homocysteine (tHcy) levels and major depressive disorder (MDD) in a large community sample with an extended age range. METHODS: A total of 3392 men and women aged 35-66 years participating in the CoLaus study and its psychiatric arm (PsyCoLaus) were included in the analyses. High tHcy measured from fasting blood samples was defined as a concentration ≥15μmol/L. MDD was assessed using the semi-structured Diagnostic Interview for Genetics Studies. RESULTS: In multivariate analyses, elevated tHcy levels were associated with greater odds of meeting the diagnostic criteria for lifetime MDD among men (OR=1.71; 95% CI, 1.18-2.50). This was particularly the case for remitted MDD. Among women, there was no significant association between tHcy levels and MDD and the association tended to be in the opposite direction (OR=0.61; 95% CI, 0.34-1.08). CONCLUSIONS: In this large population-based study, elevated tHcy concentrations are associated with lifetime MDD and particularly with remitted MDD among men.

Identificador

https://serval.unil.ch/?id=serval:BIB_07DD26F78C96

isbn:1873-3360 (Electronic)

pmid:23707477

doi:10.1016/j.psyneuen.2013.04.018

isiid:000326213700037

Idioma(s)

en

Direitos

info:eu-repo/semantics/openAccess

Fonte

Psychoneuroendocrinology, vol. 38, no. 10, pp. 2309-2318

Tipo

info:eu-repo/semantics/article

article